I. Monjo

990 total citations
59 papers, 568 citations indexed

About

I. Monjo is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, I. Monjo has authored 59 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Rheumatology, 24 papers in Pulmonary and Respiratory Medicine and 21 papers in Immunology. Recurrent topics in I. Monjo's work include Vasculitis and related conditions (24 papers), Rheumatoid Arthritis Research and Therapies (17 papers) and Otitis Media and Relapsing Polychondritis (12 papers). I. Monjo is often cited by papers focused on Vasculitis and related conditions (24 papers), Rheumatoid Arthritis Research and Therapies (17 papers) and Otitis Media and Relapsing Polychondritis (12 papers). I. Monjo collaborates with scholars based in Spain, United States and Argentina. I. Monjo's co-authors include Eugenio de Miguel, Alejandro Balsa, Elisa Fernández-Fernández, Diana Peiteado, María‐Eugenia Miranda‐Carús, Laura Nuño, Alejandro Villalba, Chamaida Plasencia‐Rodríguez, Sara García and Paloma Sánchez‐Mateos and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and Nutrients.

In The Last Decade

I. Monjo

54 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. Monjo Spain	14	360	266	148	113	64	59	568
Stephen Jarrett United Kingdom	9	409 1.1×	104 0.4×	86 0.6×	57 0.5×	72 1.1×	9	575
Olivier Espitia France	14	312 0.9×	433 1.6×	104 0.7×	113 1.0×	25 0.4×	81	718
Georgios Yiannopoulos Greece	8	274 0.8×	310 1.2×	170 1.1×	17 0.2×	16 0.3×	10	810
Noémie Assous France	8	204 0.6×	84 0.3×	136 0.9×	36 0.3×	50 0.8×	11	481
I C van Eijk Netherlands	12	483 1.3×	65 0.2×	179 1.2×	34 0.3×	20 0.3×	13	614
Frances Borg United Kingdom	12	678 1.9×	814 3.1×	86 0.6×	318 2.8×	18 0.3×	17	988
Vincenzo Pitini Italy	15	190 0.5×	162 0.6×	92 0.6×	194 1.7×	236 3.7×	48	729
Patrick Liang Canada	11	372 1.0×	452 1.7×	128 0.9×	39 0.3×	42 0.7×	16	697
Giulia Pazzola Italy	16	497 1.4×	549 2.1×	140 0.9×	131 1.2×	14 0.2×	39	751
Sven Weidner Germany	7	124 0.3×	335 1.3×	109 0.7×	98 0.9×	14 0.2×	9	445

Countries citing papers authored by I. Monjo

Since Specialization

Citations

This map shows the geographic impact of I. Monjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Monjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Monjo more than expected).

Fields of papers citing papers by I. Monjo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Monjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Monjo. The network helps show where I. Monjo may publish in the future.

Co-authorship network of co-authors of I. Monjo

This figure shows the co-authorship network connecting the top 25 collaborators of I. Monjo. A scholar is included among the top collaborators of I. Monjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Monjo. I. Monjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Novella-Navarro, Marta, Ana Maria Van Den Rym, C. López-Pedrera, et al.. (2025). Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?. Nutrients. 17(5). 820–820. 1 indexed citations

Monjo, I., et al.. (2025). Circulating PD-1hi CXCR5– and CXCR5+ CD4 T cells are elevated in patients with newly diagnosed giant cell arteritis, and predict relapse. Lara D. Veeken. 64(6). 3996–4004. 2 indexed citations

Collada, J. Molina, Isabel Castrejón, I. Monjo, et al.. (2024). Different giant cell arteritis phenotypes may present distinct types of ischaemic complications. Clinical and Experimental Rheumatology. 43(4). 668–673. 1 indexed citations

Novella-Navarro, Marta, Virginia Ruíz-Esquide, I. Monjo, et al.. (2024). Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis. Clinical Rheumatology. 43(9). 2817–2823. 1 indexed citations

Fernández-Fernández, Elisa, et al.. (2024). The influence of the cardiac cycle on the halo sign and its impact on the ultrasound diagnosis of giant cell arteritis. Lara D. Veeken. 64(3). 1459–1463. 1 indexed citations

Martínez‐Feito, Ana, Marta Novella-Navarro, Borja Hernández‐Breijo, et al.. (2024). Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases. Lara D. Veeken. 64(1). 344–351. 4 indexed citations

Novella-Navarro, Marta, Alejandro Villalba, Elisa Fernández-Fernández, et al.. (2023). Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment. RMD Open. 9(3). e003382–e003382. 7 indexed citations

Collada, J. Molina, Isabel Castrejón, I. Monjo, et al.. (2023). Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care. RMD Open. 9(2). e002970–e002970. 19 indexed citations

Juárez, Maria, Diego Benavent, Victoria Navarro‐Compán, et al.. (2023). POS0676 THE CHALLENGE OF IDENTIFYING DIFFICULT-TO-TREAT AXIAL SPONDYLOARTHRITIS IN CLINICAL PRACTICE: RESULTS FROM LA PAZ-SPA COHORT. Annals of the Rheumatic Diseases. 82. 619–620. 1 indexed citations

10.

Collada, J. Molina, Isabel Castrejón, I. Monjo, et al.. (2023). Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis: comparative study with FDG-PET/CT. RMD Open. 9(3). e003329–e003329. 7 indexed citations

11.

Fernández-Fernández, Elisa, et al.. (2023). POS0725 CRANIAL, EXTRACRANIAL AND MIXED INVOLVEMENT IN GIANT CELL ARTERITIS: ANALYSIS OF THE CLINICAL DIFFERENCES. Annals of the Rheumatic Diseases. 82. 650–651. 1 indexed citations

12.

Monjo, I., Elisa Fernández-Fernández, José María Mostaza, et al.. (2023). Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis. Arthritis Research & Therapy. 25(1). 23–23. 6 indexed citations

13.

Collada, J. Molina, Isabel Castrejón, I. Monjo, et al.. (2023). OP0171 ADDED VALUE OF FDG-PET/CT TO DETECT AORTIC INVOLVEMENT IN PATIENTS WITH ULTRASOUND PROVEN GIANT CELL ARTERITIS. Annals of the Rheumatic Diseases. 82. 113–114. 1 indexed citations

14.

Monjo, I., Elisa Fernández-Fernández, Diana Peiteado, Alejandro Balsa, & Eugenio de Miguel. (2022). Diagnostic validity of ultrasound including extra-cranial arteries in giant cell arteritis. Clinical Rheumatology. 42(4). 1163–1169. 11 indexed citations

15.

Benavent, Diego, Chamaida Plasencia‐Rodríguez, Marta Novella-Navarro, et al.. (2022). Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain. BMJ Open. 12(4). e057850–e057850. 10 indexed citations

16.

Novella-Navarro, Marta, Chamaida Plasencia, Victoria Navarro‐Compán, et al.. (2020). Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis. Arthritis Research & Therapy. 22(1). 284–284. 31 indexed citations

17.

Rodríguez‐Pardo, Jorge, et al.. (2020). Prevalence and significance of ischemic cerebrovascular events in giant cell arteritis. Medicina Clínica. 157(2). 53–57. 8 indexed citations

18.

Navarro‐Compán, Victoria, Jair Tenorio, Sara García, et al.. (2020). Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?. Orphanet Journal of Rare Diseases. 15(1). 51–51. 13 indexed citations

19.

Fernández-Fernández, Elisa, et al.. (2019). Fracturas vertebrales múltiples tras la suspensión de tratamiento con denosumab: serie de diez casos. Reumatología Clínica. 16(6). 480–484. 7 indexed citations

20.

Martínez‐Feito, Ana, Chamaida Plasencia‐Rodríguez, Victoria Navarro‐Compán, et al.. (2018). The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. Clinical Rheumatology. 38(3). 949–954. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact